ASLAN Pharmaceuticals

Investor Relations

About ASLAN

About ASLAN

ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients.

News Releases
Date Title
Sep 22, 2023
ASLAN Pharmaceuticals Announces Acceptance of Late Breaker Abstract on Eblasakimab Phase 2b Results as Oral Presentation and Three Additional Abstracts at 32nd European Academy of Dermatology and Venereology Congress
Sep 07, 2023
ASLAN Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
Aug 11, 2023
ASLAN Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Read More
Upcoming Events
More information is coming soon.
Read More
Investor Relations
E-mail: investor@aslanpharma.com